{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T20:46:17Z","timestamp":1786826777313,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008734","name":"Mitsui Sumitomo Insurance Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21mg00100007"],"award-info":[{"award-number":["JP21mg00100007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.expneurol.2022.114300","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:26:34Z","timestamp":1670930794000},"page":"114300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis"],"prefix":"10.1016","volume":"361","author":[{"given":"Shuuichi","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ishizuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seijiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2022.114300_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-981-10-2513-6_3","article-title":"The matrix metalloproteinase and tissue inhibitors of metalloproteinase balance in physiological and pathological remodeling of skeletal muscles","author":"Alameddine","year":"2017","journal-title":"Proteas. Physiol. Pathol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0010","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science."},{"key":"10.1016\/j.expneurol.2022.114300_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13063-017-2433-2","article-title":"The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial","volume":"19","author":"Birnbaum","year":"2018","journal-title":"Trials."},{"key":"10.1016\/j.expneurol.2022.114300_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/dbio.1998.8936","article-title":"Localization and regulation of MuSK at the neuromuscular junction","volume":"199","author":"Bowen","year":"1998","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnmol.2020.00159","article-title":"Myasthenia gravis with antibodies against muscle specific kinase: an update on clinical features, pathophysiology and treatment","volume":"13","author":"Cao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114300_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.23781","article-title":"Matrix metalloproteinase 3 deletion preserves denervated motor endplates after traumatic nerve injury","volume":"73","author":"Chao","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0035","doi-asserted-by":"crossref","first-page":"33752","DOI":"10.1074\/jbc.M706268200","article-title":"The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming","volume":"282","author":"Cohen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2022.114300_bb0040","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.1980.sp013145","article-title":"On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates","volume":"299","author":"Cull-Candy","year":"1980","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase musk is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.expneurol.2022.114300_bb0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1749-6632.1999.tb07754.x","article-title":"Effect of a matrix metalloproteinase inhibitor (BB-1101) on nerve regeneration","volume":"878","author":"Demestre","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2022.114300_bb0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2990.2005.00676.x","article-title":"Characterization of matrix metalloproteinases in denervated muscle","volume":"31","author":"Demestre","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.0000000000002466","article-title":"3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies","volume":"86","author":"Evoli","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.expneurol.2022.114300_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2022.114300_bb0075","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200513","article-title":"Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis","volume":"217","author":"Fichtner","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2022.114300_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.conb.2014.05.001","article-title":"Signaling mechanisms regulating Wallerian degeneration","volume":"27","author":"Freeman","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0085","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.93.6.2257","article-title":"Viruses, cytokines, antigens, and autoimmunity","volume":"93","author":"Gianani","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114300_bb0090","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"The Lancet Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.expneurol.2022.114300_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/698256","article-title":"Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies","volume":"2014","author":"Grinsell","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.expneurol.2022.114300_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2022.114300_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.expneurol.2022.114300_bb0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00415-015-7982-2","article-title":"Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis","volume":"263","author":"Jordan","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2990.1998.00118.x","article-title":"Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve","volume":"24","author":"Kherif","year":"1998","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.expneurol.2022.114300_bb0130","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/1873-3468.13095","article-title":"Irreversible modifications of receptor tyrosine kinases","volume":"592","author":"Kreitman","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2022.114300_bb0135","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","article-title":"Undulating changes in human plasma proteome profiles across the lifespan","volume":"25","author":"Lehallier","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2022.114300_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature."},{"key":"10.1016\/j.expneurol.2022.114300_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clineuro.2018.06.041","article-title":"Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients","volume":"172","author":"Li","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.expneurol.2022.114300_bb0150","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899456","article-title":"Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments","volume":"37","author":"Lichtenthaler","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2022.114300_bb0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.nmd.2020.03.012","article-title":"AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review","volume":"30","author":"Lu","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2022.114300_bb0160","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI58675","article-title":"Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice","volume":"121","author":"Ma","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2022.114300_bb0165","doi-asserted-by":"crossref","first-page":"880","DOI":"10.15252\/emmm.201607298","article-title":"DOK7 gene therapy enhances motor activity and life span in ALS model mice","volume":"9","author":"Miyoshi","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2022.114300_bb0170","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0180","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nn905","article-title":"Pre-existing pathways promote precise projection patterns","volume":"5","author":"Nguyen","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114300_bb0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2022.114300_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100302","article-title":"A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs","volume":"296","author":"Ojala","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2022.114300_bb0195","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-021-03672-3","article-title":"Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia","volume":"595","author":"Oury","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.expneurol.2022.114300_bb0200","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science."},{"key":"10.1016\/j.expneurol.2022.114300_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102561","article-title":"Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus","volume":"116","author":"Peng","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2022.114300_bb0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/nyas.13507","article-title":"Neuromuscular synapse electrophysiology in myasthenia gravis animal models","volume":"1412","author":"Plomp","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2022.114300_bb0220","doi-asserted-by":"crossref","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","author":"Shen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2022.114300_bb0225","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2022.114300_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94263","article-title":"Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis","volume":"2","author":"Stathopoulos","year":"2017","journal-title":"JCI Insight."},{"key":"10.1016\/j.expneurol.2022.114300_bb0240","doi-asserted-by":"crossref","first-page":"16977","DOI":"10.1073\/pnas.0601565103","article-title":"Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade","volume":"103","author":"Tang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114300_bb0245","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1091\/mbc.e08-07-0759","article-title":"A histone deacetylase 4\/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression","volume":"20","author":"Tang","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.expneurol.2022.114300_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101385","article-title":"DOK7 gene therapy enhances neuromuscular junction innervation and motor function in aged mice","volume":"23","author":"Ueta","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2022.114300_bb0255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury","volume":"15","author":"Valenzuela","year":"1995","journal-title":"Neuron."},{"key":"10.1016\/j.expneurol.2022.114300_bb0260","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.03.009","article-title":"Antibodies and receptors: from neuromuscular junction to central nervous system","volume":"439","author":"Vincent","year":"2020","journal-title":"Neuroscience."},{"key":"10.1016\/j.expneurol.2022.114300_bb0270","doi-asserted-by":"crossref","first-page":"50457","DOI":"10.1074\/jbc.M208664200","article-title":"MuSK glycosylation restrains MuSK activation and acetylcholine receptor clustering","volume":"277","author":"Watty","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2022.114300_bb0275","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1023\/B:NEUR.0000020631.69804.f5","article-title":"Activity dependent removal of agrin from synaptic basal lamina by matrix metalloproteinase 3","volume":"32","author":"Werle","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.expneurol.2022.114300_bb0280","first-page":"1051","article-title":"Assessing disease onset and progression in the SOD1 mouse model of ALS","volume":"14","author":"Weydt","year":"2003","journal-title":"Neuroreport."},{"key":"10.1016\/j.expneurol.2022.114300_bb0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron."},{"key":"10.1016\/j.expneurol.2022.114300_bb0290","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nmd.2020.04.003","article-title":"Double seropositivity for AChR and MuSK autoantibodies in myasthenia gravis","volume":"30","author":"Zhu","year":"2020","journal-title":"Neuromuscul. Disord."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622003259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622003259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:12:17Z","timestamp":1758003137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488622003259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":58,"alternative-id":["S0014488622003259"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114300","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114300"}}